JP2014524411A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524411A5 JP2014524411A5 JP2014523151A JP2014523151A JP2014524411A5 JP 2014524411 A5 JP2014524411 A5 JP 2014524411A5 JP 2014523151 A JP2014523151 A JP 2014523151A JP 2014523151 A JP2014523151 A JP 2014523151A JP 2014524411 A5 JP2014524411 A5 JP 2014524411A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- branched
- chain alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000000217 alkyl group Chemical group 0.000 claims 46
- 150000001875 compounds Chemical class 0.000 claims 27
- 125000000753 cycloalkyl group Chemical group 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 4
- 229910052731 fluorine Inorganic materials 0.000 claims 4
- 239000011737 fluorine Substances 0.000 claims 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 0 C1=CC=I*=C1 Chemical compound C1=CC=I*=C1 0.000 description 3
- -1 4'-carbamoylbiphenyl-4-yl Chemical group 0.000 description 1
- HMUMQJBSKMSHFK-JBSCERNYSA-N CC(C)(/C=C\C=C(/C)\OC)C1=CC=[I]C=C1 Chemical compound CC(C)(/C=C\C=C(/C)\OC)C1=CC=[I]C=C1 HMUMQJBSKMSHFK-JBSCERNYSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Cc1ccccc1 Chemical compound Cc1ccccc1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161514563P | 2011-08-03 | 2011-08-03 | |
| US61/514,563 | 2011-08-03 | ||
| PCT/CA2012/000721 WO2013016807A1 (en) | 2011-08-03 | 2012-07-31 | Insulin secretion promoting agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014524411A JP2014524411A (ja) | 2014-09-22 |
| JP2014524411A5 true JP2014524411A5 (enExample) | 2015-12-03 |
Family
ID=47628579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523151A Ceased JP2014524411A (ja) | 2011-08-03 | 2012-07-31 | インスリン分泌促進剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9371285B2 (enExample) |
| EP (1) | EP2739608B1 (enExample) |
| JP (1) | JP2014524411A (enExample) |
| CA (1) | CA2842450A1 (enExample) |
| WO (1) | WO2013016807A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2938520A1 (en) * | 2014-02-28 | 2015-09-03 | Val-Chum, Limited Partnership | Abhd6 antagonists for promoting browning of white adipose tissue and brown adipose tissue functionality |
| CN112300122A (zh) * | 2019-07-26 | 2021-02-02 | 南京理工大学 | 三氮唑类杂环化合物及其合成方法 |
| CN117120435A (zh) * | 2021-04-01 | 2023-11-24 | 小野药品工业株式会社 | Abhd6拮抗剂 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2834108A1 (en) | 2010-05-12 | 2011-11-17 | Val-Chum, Limited Partnership | Screening assays based on mag and/or abhd6 for selecting insulin secretion promoting agents |
-
2012
- 2012-07-31 US US14/236,852 patent/US9371285B2/en not_active Expired - Fee Related
- 2012-07-31 CA CA2842450A patent/CA2842450A1/en active Pending
- 2012-07-31 EP EP12819370.3A patent/EP2739608B1/en not_active Not-in-force
- 2012-07-31 JP JP2014523151A patent/JP2014524411A/ja not_active Ceased
- 2012-07-31 WO PCT/CA2012/000721 patent/WO2013016807A1/en not_active Ceased
-
2016
- 2016-05-20 US US15/160,362 patent/US9518016B2/en not_active Expired - Fee Related